Charles River has been riding rough waters in 2024, and as the CRO’s CEO predicted, the third quarter proved no exception. | ...

One of Massachusetts' major life science companies, Charles River Laboratories Inc., has revealed new details on its ongoing cost-savings initiatives, stating in an earnings call that it’s “already ...

The Wilmington-based contract research organization offered new details in its third-quarter earnings about its ongoing restructuring initiatives, including the extent of layoffs and site ...

Charles River Laboratories International Inc. could share more details this week about the “restructuring initiatives” it is ...

Charles River Laboratories raised its full-year profit forecast after beating analysts' estimates for quarterly results as the contract research firm expects demand to stabilize from biotech clients ...

Charles River Labs (CRL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

New heat pump technology under construction will pull energy out of the river and convert it to steam for heating industrial ...

Charles River Labs Q3 revenue of $1.01 billion surpassed expectations; however, revenue declined 1.6% YoY, and operating ...

Baird raised the firm’s price target on Charles River (CRL) to $211 from $190 and keeps a Neutral rating on the shares. More than 80% of ...

WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported third-quarter earnings of $69.7 million. On a per-share basis, the ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based therapies for chronic diseases. The agreement will involve the ...